Comparison of VIA with molecular testing using HPV DNA and the biomarker p16INK4a/Ki67 for cervical cancer screening in a high prevalent cervical cancer setting

Citation:

Orang'o, E.O., et al., 2017. Comparison of VIA with molecular testing using HPV DNA and the biomarker p16INK4a/Ki67 for cervical cancer screening in a high prevalent cervical cancer setting. In Eurogin 2017. October 9, 2017. Amsterdam, Netherlands, p. Abstract number #00529 .

Date Presented:

October 9, 2017